D. Baybağ Et Al. , "Development and efficacy of a novel monoclonal antibody targeting CX3CR1 for pain relief in pancreatic cancer and chronic pancreatitis," 56th EPC Meeting , A-Coruna, Spain, pp.4, 2024
Baybağ, D. Et Al. 2024. Development and efficacy of a novel monoclonal antibody targeting CX3CR1 for pain relief in pancreatic cancer and chronic pancreatitis. 56th EPC Meeting , (A-Coruna, Spain), 4.
Baybağ, D., Çevik, N. C., Kavaklıoğlu, B., Sığırlı, S., Karakaş Zeybek, D., Demir, E., ... Ceyhan, G. O.(2024). Development and efficacy of a novel monoclonal antibody targeting CX3CR1 for pain relief in pancreatic cancer and chronic pancreatitis . 56th EPC Meeting (pp.4). A-Coruna, Spain
Baybağ, Deniz Et Al. "Development and efficacy of a novel monoclonal antibody targeting CX3CR1 for pain relief in pancreatic cancer and chronic pancreatitis," 56th EPC Meeting, A-Coruna, Spain, 2024
Baybağ, Deniz Et Al. "Development and efficacy of a novel monoclonal antibody targeting CX3CR1 for pain relief in pancreatic cancer and chronic pancreatitis." 56th EPC Meeting , A-Coruna, Spain, pp.4, 2024
Baybağ, D. Et Al. (2024) . "Development and efficacy of a novel monoclonal antibody targeting CX3CR1 for pain relief in pancreatic cancer and chronic pancreatitis." 56th EPC Meeting , A-Coruna, Spain, p.4.
@conferencepaper{conferencepaper, author={Deniz Baybağ Et Al. }, title={Development and efficacy of a novel monoclonal antibody targeting CX3CR1 for pain relief in pancreatic cancer and chronic pancreatitis}, congress name={56th EPC Meeting}, city={A-Coruna}, country={Spain}, year={2024}, pages={4} }